A catheter system that delivers therapy directly to a blocked
artery may someday change our treatment of atherosclerosis and
its complications.
FDA scientists, together with colleagues throughout the world,
are conducting animal studies on a catheter system that carries
a tiny syringe to a blocked artery. At the blockage site, the
syringe injects drugs or other treatments directly into or around
the artery wall.
Endobionics Microsyringe
In clinical practice, this system could allow doctors to direct
their treatment to the exact location of a blockage. Furthermore,
this could allow doctors to evaluate each patient’s condition
and deliver the most appropriate drug and dose, thus reducing
complications and increasing treatment effectiveness.
